SCHEMBL442330

SCHEMBL442330

CCc1ccc2c(c1)CCCC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
TRPA1 O75762 1/20 0.43
CETP P11597 1/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2A6 P11509 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
RXRB P28702 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
HTT P42858 1/20 0.40
ADCY8 P40145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30361595 1.00 NPC1 (0.53) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL4255018 0.98 NPC1 (0.56) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL21390901 0.98 NPC1 (0.51) NPC1RAB9AMAPTMEN1KMT2A
Dimethylamine SCHEMBL6378361 0.94 NPC1 (0.53) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL17666102 0.93 NPC1 (0.46) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL10263577 0.83 SRD5A1 (0.44) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL14886104 0.83 HTR2C (0.52) ADCY8ADCY1CYP2D6ADRA2AADRA2B
SCHEMBL14419145 0.83 HRH3 (0.49) CYP1A2CYP2D6CYP2C19
SCHEMBL24451656 0.81 PNMT (0.43) ADRA2AADRA2BADRA2C
SCHEMBL12018680 0.81 ASIC3 (0.43) NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114829549-B Production of linear alpha olefins from organosulfides 沙特阿拉伯石油公司 2023-06-02 CN claimed
CN-114829549-A Production of linear alpha olefins from organic sulfides 沙特阿拉伯石油公司 2022-07-29 CN claimed
US-11046624-B1 Production of linear alpha olefins from organic sulfides SAUDI ARABIAN OIL COMPANY (SA) 2021-06-29 US claimed
WO-2021119521-A1 PRODUCTION OF LINEAR ALPHA OLEFINS FROM ORGANIC SULFIDES SAUDI ARABIAN OIL COMPANY (SA) 2021-06-17 WO claimed
US-20210179512-A1 PRODUCTION OF LINEAR ALPHA OLEFINS FROM ORGANIC SULFIDES SAUDI ARABIAN OIL COMPANY (SA) 2021-06-17 US claimed
EP-0192492-B1 PEPTIDES CONTAINING AN ALIPHATIC-AROMATIC KETONE SIDE CHAIN THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1992-01-02 EP claimed
US-20240244957-A1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL Merck Patent KGaA (DE) 2024-07-18 US disclosed
CN-118215656-A Cyclic acetals and ketals for photoinduction-released active aldehydes and ketones 弗门尼舍有限公司 2024-06-18 CN disclosed
EP-3807367-B1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2023-07-19 EP disclosed
CN-114829549-B Production of linear alpha olefins from organosulfides 沙特阿拉伯石油公司 2023-06-02 CN disclosed
US-20230151235-A1 FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
EP-3552252-B1 PREPARATION PROCESS FOR AN ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2023-05-17 EP disclosed
US-11603479-B2 Formulation of an organic functional material MERCK KGAA (DE) 2023-03-14 US disclosed
US-20030162992-A1 Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde PHARMASSET, INC. 2003-08-28 US disclosed
WO-2003063771-A2 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS PHARMASSET LTD. (BB) 2003-08-07 WO disclosed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
WO-2003051306-A2 N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
US-20020165421-A1 Process for the manufacture of temperature-sensitive polymers SOLUTIA INC. 2002-11-07 US disclosed
WO-2002083812-A1 PROCESS FOR THE MANUFACTURE OF TEMPERATURE-SENSITIVE POLYMERS SOLUTIA INC. (US) 2002-10-24 WO disclosed
EP-0721938-A1 Alkyl(hetero)cyclic compounds, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1996-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179512-A1 PRODUCTION OF LINEAR ALPHA OLEFINS FROM ORGANIC SULFIDES CBS, SRMS, CYP2S1 NPC1 3450/4885RAB9A 2466/4885MAPT 3629/4885
US-20030162992-A1 Reacting a 2,2-dialkoxyethyl halide with an appropriate carboxylate compound to obtain acetal compound; hydrolyzing the acetal to form the alpha -acyloxyacetaldehyde DERA, DPYD, DHPS NPC1 4055/4885RAB9A 3285/4885MAPT 3554/4885
US-11046624-B1 Production of linear alpha olefins from organic sulfides CBS, SRMS, CYP2S1 NPC1 3527/4885RAB9A 2634/4885MAPT 3746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.